Impact of relatively new chemotherapeutic agents on the outcome of Egyptian patients with advanced malignant pleural mesothelioma

Gaafar R; Khaled H; Sallam Y.A.; Shafik H; Aboulkassem F.A.; Emara M

doi:10.2478/fco-2014-0005

Forum of Clinical Oncology (Aug 2014)

Impact of relatively new chemotherapeutic agents on the outcome of Egyptian patients with advanced malignant pleural mesothelioma

Gaafar R,
Khaled H,
Sallam Y.A.,
Shafik H,
Aboulkassem F.A.,
Emara M

Affiliations

Gaafar R: Medical Oncology Department, NCI, Cairo University, Egypt
Khaled H: Medical Oncology Department, NCI, Cairo University, Egypt
Sallam Y.A.: Medical Oncology Department, NCI, Cairo University, Egypt
Shafik H: Medical Oncology Department, NCI, Cairo University, Egypt
Aboulkassem F.A.: Medical Oncology Department, NCI, Cairo University, Egypt
Emara M: Medical Oncology Department, NCI, Cairo University, Egypt

DOI: https://doi.org/10.2478/fco-2014-0005
Journal volume & issue: Vol. 5, no. 1
pp. 29 – 36

Abstract

Read online

Purpose: Patients with malignant pleural mesothelioma (MPM) are well known to have poor response to chemotherapy. The aim of this work was to evaluate the efficacy and safety of new chemotherapeutic agents for the treatment of Egyptian MPM patients.

Published in Forum of Clinical Oncology

ISSN: 1792-362X (Online)
Publisher: Sciendo
Country of publisher: Poland
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://sciendo.com/journal/FCO

About the journal

Abstract

Keywords